InsidersTradesSigma
Track the 엑세스바이오 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 엑세스바이오 has published 1 reports. Market capitalisation: €75.8bn. The latest transaction was reported on 12 March 2026 (Other). Among the most active insiders: 엑세스바이오. All data is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Access Bio 属于健康和制药行业，在XKRX市场上市。该公司专注于创新医疗诊断的开发。